Skip to Main Content

Author Details

Naomi Miller
Campbell Family Institute for Breast Cancer Research, University Health Network
1985
55
27
PMIDPaper TitleJournal TitlePublished Year
28781102Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.Breast2018
29093438Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma.Nat Commun2017
25527357B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.Cancer Immunol Res2015
26391856Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.Acad Radiol2015
26185737Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis.Springerplus2015
25964246Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.J Clin Oncol2015
23708664Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.Oncogene2014
25220719Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.Int J Radiat Oncol Biol Phys2014
24831777Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues.Breast Cancer Res Treat2014
24753984Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.Am J Nucl Med Mol Imaging2014
23064777Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast.Ann Surg Oncol2013
23708085Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.Int J Radiat Oncol Biol Phys2013
23456231Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.Breast Cancer Res Treat2013
22178456Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.Cancer Treat Rev2012
23300357Testing for her2 in breast cancer: current pathology challenges faced in Canada.Curr Oncol2012
22363530Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.PLoS One2012
22124102Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.J Clin Oncol2012
21393507MicroRNA-301 mediates proliferation and invasion in human breast cancer.Cancer Res2011
21679412Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.BMC Cancer2011
20981137Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast.Cancer Inform2010
19290006Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.Lab Invest2009
20191105Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.Biomed Inform Insights2009
19760610Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.Genes Chromosomes Cancer2009
19443366Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.Anticancer Res2009
19299408Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?Ann Oncol2009
18779878Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.Cancer Inform2008
17845726Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.BMC Cancer2007
15734956The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer.Cancer Epidemiol Biomarkers Prev2005
16166334High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.Cancer Res2005
15173271Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates.J Natl Cancer Inst2004
12569575Dysregulated PTEN-PKB and negative receptor status in human breast cancer.Int J Cancer2003
11906438In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma.Breast J2001
11303594Growth factors and stromal matrix proteins associated with mammographic densities.Cancer Epidemiol Biomarkers Prev2001
10661345An analysis of 78 breast sarcoma patients without distant metastases at presentation.Int J Radiat Oncol Biol Phys2000
10515895Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.Blood1999
10091736Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.Cancer1999
9869520Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.Ann Surg Oncol1998
9150899Feasibility of obtaining breast epithelial cells from healthy women for studies of cellular proliferation.Breast Cancer Res Treat1997
8640413Squamous cell carcinoma of the breast.Can Assoc Radiol J1996
8926389The potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer.Int J Hyperthermia1996
8883964Male breast cancer: an 11 year review of 66 patients.Breast Cancer Res Treat1996
8530625Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506.J Clin Endocrinol Metab1995
7519528Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice.Clin Endocrinol (Oxf)1994
32370444Thyroid lymphomas in human thyroid tissue with autoimmune thyroid disease xenografted in severe combined immunodeficient mice.Endocr Pathol1994
8106624Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.J Clin Endocrinol Metab1994
7914445Studies of human thyroid xenografts from Hashimoto's thyroiditis in severe combined immunodeficient (SCID) mice: detection of thyroid stimulation-blocking antibody.Thyroid1994
7835825Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease.Horm Metab Res1994
7678424Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis.J Clin Endocrinol Metab1993
8100830Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice.J Clin Endocrinol Metab1993
1902846Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.J Clin Endocrinol Metab1991
  • 1 - 50 of 55

Recommended Authors

Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 2
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 1
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 1
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 1
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year 2000
Number of shared co-authors 3
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Sarah L Blair
University of California
Career Start Year 1996
Number of shared co-authors 0
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Amy C Degnim
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 1
Elizabeth L Salisbury
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 0
Peter Bult
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 0
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 1
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 2
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 11
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 0
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 0
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 1
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 2
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 3
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 1
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 2
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 2
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 2
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 7

Collaborators

Susan J Done
University Health Network
Co-authored papers 14
Bruce Youngson
University Health Network
Co-authored papers 13
David R McCready
University of Toronto, University Health Network
Co-authored papers 12
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 6
Wey L Leong
University Health Network
Co-authored papers 4
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Co-authored papers 4
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Paul C Boutros
University of California los angeles
Co-authored papers 3
Norman F Boyd
Co-authored papers 3
Vladimir Iakovlev
St. Michael's Hospital, University of Toronto
Co-authored papers 3
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Thomas R Cawthorn
Sick Kids Hospital
Co-authored papers 2
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Angela B Y Hui
Stanford University
Co-authored papers 2
Juan Moreno
University of Toronto
Co-authored papers 2
Keisha Warren
Co-authored papers 2
Dong-Yu Wang
College of Pharmaceutical Sciences, Shanghai Jiao Tong University
Co-authored papers 2
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 2
Nona Arneson
Ontario Cancer Institute, Princess Margaret Hospital
Co-authored papers 2
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 2
Levi Waldron
City University of New York School of Public Health
Co-authored papers 2
Kate Gerster
Ontario Cancer Institute
Co-authored papers 2
Paola Cappello
University of Turin
Co-authored papers 1
Natalie S Fox
University of California los angeles
Co-authored papers 1
George Tomlinson
University Health Network
Co-authored papers 1
Jennifer P Y Lee
The Hospital for Sick Children Research Institute
Co-authored papers 1
Syed Haider
Institute of Cancer Research
Co-authored papers 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 1
Alexandra M Easson
University of Toronto
Co-authored papers 1
Release 1.2